Bio-Rad QX200 Droplet Digital PCR (ddPCR) System

Notice of Intent: Bio-Rad QX200 Droplet Digital PCR (ddPCR) System. (75N98026Q01194) The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bio-rad Laboratories, Inc. under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The National Institutes of Health (NIH), [Institute/Center], intends to solicit and negotiate on a sole-source basis with Bio-rad Laboratories, Inc. for the acquisition of Bio-Rad QX200 Droplet Digital PCR (ddPCR) System. Bio-Rad Laboratories is the sole manufacturer and provider of the QX200 ddPCR system and its proprietary droplet-based digital PCR technology. The system employs a unique microfluidic droplet partitioning approach that enables absolute quantification of nucleic acid targets with high precision and sensitivity. No alternative commercially available system provides the specific combination of capabilities. This notice is not a request fo…

Excerpt as published. The complete description, attachments, and any amendments are on the official notice.